| | POLISH FINANCIAL SUPERVISION AUTHORITY | |
| |
| | | UNI - EN REPORT No | 124 | / | 2012 |
| | |
| | Date of issue: | 2012-12-05 | | | | | | | | |
| | Short name of the issuer | | | | | | | |
| | SOPHARMA AD | |
| | Subject | | | | | | | | | | |
| | current report 124 inf. za kfn11.2012 ENG | |
| | Official market - legal basis | | | | | | |
| | Art. 160 ust 4 Ustawy o obrocie - informacja o transakcjach osуb maj№cych dostкp do informacji poufnych
| |
| | Unofficial market - legal basis | | | | | |
| | Contents of the report: | | | | | | | | |
| | The Board of Directors of Sopharma AD (the “Company") notifies that for November 2012 sales revenues remained at the same level compared to the same period of 2011, including 1% increase of export sales and no changes in domestic sales.
During the first eleven months of this year Sopharma AD recorded an increase of sales revenues of 2%, including 9% decrease of domestic sales and 6% increase of export sales compared to the same period of 2011.
| |
| | Annexes | | | | | | | | | | |
| | File | Description | |
| |
current report 124 inf. za kfn11.2012 ENG.doc | current report 124 inf. za kfn11.2012 ENG | |
